EquityFlow › Companies › Tridek-One

Tridek-One

Biotech · Paris, FR

Biotech developing CD31 agonists to restore immune balance for autoimmune disease

Funding history

DateRoundAmount
Sep 2022Series A
Tridek-One, a Paris autoimmune biotech, raised $16.1M led by Pureos Bioventures.
$16.1M

Investors

BpifrancePureos Bioventures

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →